- Home
- SXTC vs OPP Comparison
SXTC vs OPP Comparison
Compare SXTC & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- OPP
- Stock Information
- Founded
- SXTC 2005
- OPP 2010
- Country
- SXTC China
- OPP United States
- Employees
- SXTC N/A
- OPP N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- OPP Finance/Investors Services
- Sector
- SXTC Health Care
- OPP Finance
- Exchange
- SXTC Nasdaq
- OPP Nasdaq
- Market Cap
- SXTC 184.5M
- OPP 204.0M
- IPO Year
- SXTC 2019
- OPP N/A
- Fundamental
- Price
- SXTC $1.35
- OPP $7.98
- Analyst Decision
- SXTC
- OPP
- Analyst Count
- SXTC 0
- OPP 0
- Target Price
- SXTC N/A
- OPP N/A
- AVG Volume (30 Days)
- SXTC 244.1K
- OPP 108.0K
- Earning Date
- SXTC 01-01-0001
- OPP 01-01-0001
- Dividend Yield
- SXTC N/A
- OPP 14.41%
- EPS Growth
- SXTC N/A
- OPP N/A
- EPS
- SXTC N/A
- OPP N/A
- Revenue
- SXTC $1,740,907.00
- OPP N/A
- Revenue This Year
- SXTC N/A
- OPP N/A
- Revenue Next Year
- SXTC N/A
- OPP N/A
- P/E Ratio
- SXTC N/A
- OPP N/A
- Revenue Growth
- SXTC N/A
- OPP N/A
- 52 Week Low
- SXTC $0.95
- OPP $7.26
- 52 Week High
- SXTC $7.84
- OPP $8.83
- Technical
- Relative Strength Index (RSI)
- SXTC 47.18
- OPP 37.73
- Support Level
- SXTC $1.32
- OPP $7.91
- Resistance Level
- SXTC $1.65
- OPP $8.03
- Average True Range (ATR)
- SXTC 0.13
- OPP 0.09
- MACD
- SXTC 0.00
- OPP 0.00
- Stochastic Oscillator
- SXTC 12.77
- OPP 29.82
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.